| scholarly article | Q13442814 |
| P50 | author | Brian R. Murphy | Q65658906 |
| P2093 | author name string | P L Collins | |
| P L Ogra | |||
| T Kanesaki | |||
| P2860 | cites work | Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection | Q34078039 |
| Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 | ||
| IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans | Q34614781 | ||
| Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein | Q35596022 | ||
| Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats | Q36903965 | ||
| Immunoglobulin A monoclonal antibodies protect against Sendai virus | Q36917189 | ||
| Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. | Q36920250 | ||
| Mechanisms of immunity to respiratory syncytial virus in cotton rats | Q37103582 | ||
| Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity | Q37401975 | ||
| Induction of the mucosal immune response | Q39538158 | ||
| Respiratory syncytial virus. I. Concentration and purification of the infectious virus | Q39870690 | ||
| Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants | Q39990884 | ||
| Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies | Q40181974 | ||
| The Immunologic Response to Infection with Respiratory Syncytial Virus in Infants | Q40924061 | ||
| Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system | Q41028623 | ||
| Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues | Q41632896 | ||
| Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial | Q44195643 | ||
| Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. | Q44262730 | ||
| Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine. | Q44425579 | ||
| Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness | Q44526388 | ||
| Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses | Q44653723 | ||
| An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test | Q44693028 | ||
| Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity | Q45795146 | ||
| Monoclonal antibodies protect against respiratory syncytial virus infection in mice | Q45804443 | ||
| Protective effect of antibody to parainfluenza type 1 virus | Q45824738 | ||
| Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus | Q45828635 | ||
| Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection | Q45830786 | ||
| Combined oral/nasal immunization protects mice from Sendai virus infection | Q45842357 | ||
| Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants | Q45843845 | ||
| Live respiratory syncytial virus vaccine administered parenterally | Q45889949 | ||
| Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine | Q47685496 | ||
| Maternal determinants of neonatal immune response to ovalbumin: effect of breast feeding on development of anti-ovalbumin antibody in the neonate | Q69739713 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 657-663 | |
| P577 | publication date | 1991-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus | |
| P478 | volume | 65 |
| Q40329093 | Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors. |
| Q51696281 | Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routes. |
| Q35900617 | Enteric immunization of mice against influenza with recombinant vaccinia |
| Q37249251 | Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety |
| Q35922495 | Immunization against rabies with plant-derived antigen |
| Q35838661 | Mucosal immunity: overcoming the barrier for induction of proximal responses. |
| Q41522458 | Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system |
| Q51696284 | Nasal vaccination induces protective immunity without immunopathology. |
| Q36665647 | Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques |
| Q35868774 | Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza |
| Q33975703 | Vaccination strategies for mucosal immune responses |
Search more.